Review
Accepted on 29 Sep 2025
"Evaluating the combined efficacy of Telisotuzumab Vedotin and Artificial Intelligence in the Treatment of Non-squamous Non-Small Cell Lung Cancer: A Narrative Review focusing on pharmaceutical and technical insights."
in Thoracic Oncology
- 330 views